Early-child MMRV change, Hep B/COVID votes pushed for today, $3.5B 89bio deal, Opzelura label expands, Regeneron breakthrough, Mounjaro goes pediatrics and more (Sept 12-18, 2025).
ACIP votes, Roche–89bio deal, Regeneron’s FOP…
Early-child MMRV change, Hep B/COVID votes pushed for today, $3.5B 89bio deal, Opzelura label expands, Regeneron breakthrough, Mounjaro goes pediatrics and more (Sept 12-18, 2025).